Form 4 for TMO Thermo Fisher Scientific
Accepted 2026-08-13 16:01:52 ET · period of report 2026-08-11 · accession 0000097745-26-000149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-13 16:01 | 2026-08-11 | TMO | Shafer Michael D | EVP | M - OptEx | $370.58 | +25.5K | 35.3K | +260% | +$9.45M |
| DMT | 2026-08-13 16:01 | 2026-08-11 | TMO | Shafer Michael D | EVP | S - Sale+OE | $600.00 | -25.5K | 21.0K | -55% | -$15.30M |
| DMT | 2026-08-13 16:01 | 2026-08-11 | TMO | Shafer Michael D | EVP | M - OptEx | $0.00 | -25.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-11 | M | A | 11,200 | $309.63 | 32,194.03 | D | — | — | (F1) Includes 44.079 shares acquired under the Issuer's employee's stock purchase plan on May 15, 2026. |
| 2 | Common | Common Stock | 2026-08-11 | S | D | 11,200 | $600.00 | 20,994.03 | D | — | — | (F2) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2025. |
| 3 | Common | Common Stock | 2026-08-11 | M | A | 14,300 | $418.32 | 35,294.03 | D | — | — | |
| 4 | Common | Common Stock | 2026-08-11 | S | D | 14,300 | $600.00 | 20,994.03 | D | — | — | (F2) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2025. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-08-11 | M | D | 11,200 | $0.00 | 0 | D | $309.63 · — to 2027-02-25 | 11,200 Common Stock | (F3) The options vested in four equal installments on February 25, 2021, 2022, 2023, and 2024. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-08-11 | M | D | 14,300 | $0.00 | 0 | D | $418.32 · 2024-03-09 to 2027-09-09 | 14,300 Common Stock |